Radiopharmaceutical therapy is rapidly expanding, propelled by scientific and investment momentum. This paper analyzes the ...

Journal of Nuclear Medicine March 2026, jnumed.125.271976; DOI: https://doi.org/10.2967/jnumed.125.271976 ...

Journal of Nuclear Medicine June 2026, jnumed.125.271392; DOI: https://doi.org/10.2967/jnumed.125.271392 ...

The clinical presentations of early idiopathic Parkinson disease (IPD) substantially overlap with those of atypical parkinsonian syndromes such as multiple system atrophy (MSA) and progressive ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

VOIs that represented only gray matter with a high likelihood of having elevated F 18 Florbetapir uptake in Aβ-positive subjects were delineated anatomically but were refined using an unbiased ...

Cancer remains one of the leading causes of death worldwide (1). Although morphologic imaging techniques to detect and monitor malignant diseases have advanced over the last few decades, limitations ...

This article reviews routine quality-control (QC) procedures for current nuclear medicine instrumentation, including the survey meter, dose calibrator, well counter, intraoperative probe, organ ...

The application of radiopharmaceutical therapy for the treatment of certain diseases is well established, and the field is expanding. New therapeutic radiopharmaceuticals have been developed in recent ...

Correlation of [68 Ga]Ga-RAYZ-8009 PET/CT Uptake with Immunohistochemical Glypican-3 Expression in Hepatocellular Carcinoma: A Proof-of-Target Study ...

Coronary heart disease is a leading cause of death in the United States and the most prevalent form of cardiovascular disease, affecting 16 million people. Gated SPECT cardiac perfusion imaging plays ...

Neuroendocrine neoplasms encompass a diverse range of tumors, primarily originating in the lungs and gastroenteropancreatic sites. The classification of gastroenteropancreatic neuroendocrine neoplasms ...